Binliang Liu, Shao Bin, Yi-Fei Chen, Zhanhong Chen, Xiaohong Wu, Ying Zhang, Fangyuan Dong, Tao Sun, Tao Wu, Lu Gan, Hong Zong, Quchang Ouyang. "A new option for post-CDK4/6is resistance era? Multicenter real-world study of anlotinib-based combination therapy in hormone receptor-positive metastatic breast cancer resistant to CDK4/6 inhibitors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13059